Julie So-Young Kim

President and CEO at Takeda Pharmaceutical Company Limited

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 months
Director since
2026

4 months of board service in total across 1 board, counting each seat separately. Longest: Takeda Pharmaceutical Company Limited, 4 months.

Takeda Pharmaceutical Company Limited Director · President and CEO
4 months · Since 2026

Chief executive roles

Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 10, 2026 Takeda Pharmaceutical Company Limited Open-market sale −89,090 $17.10 $1,523,439
Jul 1, 2026 Takeda Pharmaceutical Company Limited Grant or award +50,434 — —
Jul 1, 2026 Takeda Pharmaceutical Company Limited Grant or award +22,800 — —

Questions about Julie So-Young Kim

What boards is Julie So-Young Kim on?

Julie So-Young Kim sits on the board of Takeda Pharmaceutical Company Limited.

What company is Julie So-Young Kim the CEO of?

Julie So-Young Kim is President and CEO of Takeda Pharmaceutical Company Limited.

How long has Julie So-Young Kim served on boards?

Our records show at least 4 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.